Mayo Clinic's AI Detects Heart Disease from ECGs, Saves 45-Minute Assessments in Seconds
Leading academic medical center, #1 ranked hospital in the US
The Challenge
Mayo Clinic sees millions of patients annually, generating enormous volumes of medical data — ECGs, imaging, lab results, clinical notes. Critical conditions like low ejection fraction, cardiac amyloidosis, and precancerous polyps were often caught too late because detection required specialized testing that wasn't ordered during routine visits. In nephrology, assessing total kidney volume from dozens of images took 45 minutes per patient. The opportunity was clear: use AI to detect conditions earlier from data that was already being collected.
The Solution
Mayo Clinic built an AI platform spanning multiple departments. In cardiology, AI algorithms detect heart pump problems and diseases like hypertrophic cardiomyopathy from routine ECG readings — conditions previously requiring stress tests or specialized imaging. An FDA-cleared algorithm was commercialized through spinoff Anumana and adapted for Apple Watch ECG signals. In nephrology, AI automates kidney volume assessment. The Mayo Clinic Platform (MCP) provides a secure cloud-based data science environment accelerating research across the institution. An AI Factory built on Google Vertex AI facilitates application development.
The Results
AI improved order prediction accuracy from 75% to 95% for detecting cardiac conditions from routine ECGs
AI reduced kidney volume assessment from 45 minutes per patient to seconds
ML model forecasts ICU bed availability, applied to RSV capacity planning in Children's Center
MCP processes structured EHR data for 15,000 patients in about a week, model training in ~10 minutes
“AI allows us to find disease where we previously could not. An ECG is a 10-second, $10 test — if AI can detect conditions from that data that previously required a $3,000 specialized test, the impact on patient outcomes is profound.”
Key Takeaways
The biggest AI wins in healthcare come from extracting new insights from data that's already being collected
FDA-cleared AI algorithms can be commercialized as spinoff products (Anumana) — creating new revenue streams
Cloud-based AI platforms accelerate research by making data accessible and models trainable in minutes vs. months
Start with specific clinical use cases where AI impact is measurable before expanding institution-wide
Sources: Based on publicly reported data from Mayo Clinic, MIT Sloan Management Review, Nature, CB Insights, and Mayo Clinic Press
Ready for Results Like These?
Our implementation team can help you achieve similar results. Book a free consultation to get a custom AI strategy for your healthcare business.